George L. Bakris, MD, John M. Burkart, MD, Eric D

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Intensive Hemodialysis, Treatment Complications and Tolerability

Intensive Hemodialysis, Treatment Complications and Tolerability

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Intensive Hemodialysis and Health-related Quality of Life

Intensive Hemodialysis and Health-related Quality of Life

Intensive Hemodialysis and Potential Risks with Increasing Treatment

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.

Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Development of Reduced Kidney Function in Rheumatoid Arthritis

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

Intensive Hemodialysis and Health-Related Quality of Life

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey Varun Agrawal, MD, Amit K.

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients John T. Daugirdas, MD, Thomas.

Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.

Evaluation of the Potential Living Kidney Donor

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Erratum Regarding “Ultrasound Monitoring to Detect Access Stenosis in Hemodialysis Patients: A Systematic Review” (Am J Kidney Dis. 2008;51(4): )

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

Michael Copland, MD, Paul Komenda, MD, Eric D

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder.

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities Steven M. Brunelli, MD, MSCE, Adam G. Walker,

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Intensive Hemodialysis and Potential Risks With Increasing Treatment

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)

Risk for Incident Renal Dialysis in a Managed Care Population

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Michael Allon, MD American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Soluble CD14 and Endotoxin Levels in Hemodialysis Patients: A Tale of 2 Molecules Victor F. Seabra, MD, George Thomas, MD, MPH, Bertrand L. Jaber, MD,

This Month in AJKD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Maristela Böhlke, PhD American Journal of Kidney Diseases

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use George L. Bakris, MD, John M. Burkart, MD, Eric D. Weinhandl, PhD, MS, Peter A. McCullough, MD, MPH, Michael A. Kraus, MD American Journal of Kidney Diseases Volume 68, Issue 5, Pages S15-S23 (November 2016) DOI: 10.1053/j.ajkd.2016.05.026 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Distribution of predialysis systolic blood pressure in the Dialysis Outcomes and Practice Patterns Study Practice Monitor, December 2015.7 American Journal of Kidney Diseases 2016 68, S15-S23DOI: (10.1053/j.ajkd.2016.05.026) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Effects of intensive versus conventional hemodialysis on predialysis systolic blood pressure in the Frequent Hemodialysis Network (FHN) Daily Trial,42 FHN Nocturnal Trial,42 and Canadian trial of nocturnal hemodialysis.46 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. American Journal of Kidney Diseases 2016 68, S15-S23DOI: (10.1053/j.ajkd.2016.05.026) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Mean number of prescribed antihypertensive medications at baseline, month 4, and month 12 of the Frequent Hemodialysis Network (FHN) Daily Trial.42 Dashed bars span 1 standard deviation above and below the mean. American Journal of Kidney Diseases 2016 68, S15-S23DOI: (10.1053/j.ajkd.2016.05.026) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Mean number of prescribed antihypertensive medications at baseline, month 4, and month 12 of the Frequent Hemodialysis Network (FHN) Nocturnal Trial.42 Dashed bars span 1 standard deviation above and below the mean. American Journal of Kidney Diseases 2016 68, S15-S23DOI: (10.1053/j.ajkd.2016.05.026) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions